NYSE · Healthcare
Trulieve Cannabis Corp. (TRLV)
As-reported financials and recent SEC filings for Trulieve Cannabis Corp., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$1.18B
Net income
$-122.2M
Net margin
-10.3%
Diluted EPS
$-0.58
ROE
-10.7%
P/E (TTM)
—
Market cap
$1.73B
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.18B | $1.19B | $1.13B | $1.22B | $931.9M |
| Gross profit | $711.2M | $715.7M | $588.6M | $689.1M | $566.6M |
| Operating income | $143.5M | $97.8M | $-221.6M | $50.2M | $204.1M |
| Net income | $-122.2M | $-160.6M | $-533.1M | $-252.7M | $17.4M |
| Diluted EPS | $-0.58 | $-0.79 | $-2.28 | $-0.95 | $0.21 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →DEFA14A2026-06-25
View on EDGAR →DEF 14A2026-06-25
View on EDGAR →42026-06-25
View on EDGAR →42026-06-22
View on EDGAR →1442026-06-17
View on EDGAR →PRE 14A2026-06-12
View on EDGAR →8-K2026-06-12
View on EDGAR →Go deeper on TRLV
Search Trulieve Cannabis Corp.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.